Indian drugmaker Anthem Biosciences filed for a 33.95-billion-rupee ($397 million) initial public offering, draft papers ...

The latest health updates include Anthem Biosciences' IPO, France's bird flu outbreaks impacting disease-free status, China's ...

Anthem Biosciences Ltd IPO 1970 - Get Anthem Biosciences Ltd open and close date, listing date, price band, IPO lot size, allotment, subscription status, review, key insights, and much more only at Bu ...

The Bengaluru-based pharma company is run by Ajay Bhardwaj, a former Biocon executive, who is the founder, CEO and Managing Director at Anthem Biosciences. The company was incorporated in 2006.

Indian contract drugmaker Anthem Biosciences files for $397 million IPO amid booming Indian market for public offerings.

The IPO is entirely an OFS, the company will not receive any funds from the issue and the proceeds will go to the selling ...

A round-up of recent pharmaceutical news includes Anthem Biosciences filing for an IPO, China's defense of its COVID-19 ...

The IPO comprises of fresh issuance of shares worth Rs 500 crore, and an offer-for-sale of Rs 100 crore worth shares by promoters, as per the draft papers filed on December 30.

(Reuters) -Indian contract drugmaker Anthem Biosciences filed for a 33.95-billion-rupee ($397 million) initial public ...

The proposed initial public offer (IPO) is entirely an offer for sale (OFS) worth ₹3,395 crore by promoters, investors and ...

Anthem Biosciences has filed its DRHP for an IPO. The issue comprises an offer for sale of up to Rs 3,395 crore by promoters ...

Anthem Biosciences, a CRDMO specializing in drug discovery, development and manufacturing, has filed draft papers with Sebi ...